Our data showed that PHI had a good anti-inflammatory effect in mice with CCl4-induced liver fibrosis, which represented as the reduction of serum LPS, MIP-1 and TNF-α levels as well as the decreased expressions of three inflammatory factors (IL-1β, IL-6, and TNF-α) in liver tissue. Here, IL1B is linked to Hepatic fibrosis.